MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2022 International Congress

    The role of stimulation parameters on cognitive performance in Essential Tremor with DBS ViM

    J. Kane, J. Neimat, S. Wylie, F. Phibbs, P. Hedera, V. Holiday, N. van Wouwe (Louisville, USA)

    Objective: We examined the role of DBS stimulation parameters on action control performance in ET. Background: DBS is an effective treatment for the motor symptoms…
  • 2022 International Congress

    Motor resonance flexibility to emotion-enriched context in Parkinson’s disease patients with and without freezing of gait.

    E. Pelosin, G. Lagravinese, A. Bisio, M. Bove, A. Botta, G. Bonassi, R. Marchese, S. Mezzarobba, P. Ruggeri, L. Avanzino (Genova, Italy)

    Objective: This study aims at exploring the response of the mirror neuron system, specifically motor resonance, to an emotion-enriched context in people with Parkinson disease…
  • 2022 International Congress

    Emotion Recognition and Risk-Taking Behaviour in Early Parkinson’s Disease

    A. Slomp, D. de Waard, S. Vander Zee, S. Slingerland, J. Boertien, J. Spikman, T. van Laar, R. Huitema (Groningen, Netherlands)

    Objective: To assess the association between facial emotion recognition and traffic-related risk-taking behaviour in early Parkinson’s Disease (PD) patients. Background: Risk-taking behaviour is an important…
  • 2022 International Congress

    Olfactory dysfunction in patients with Huntington disease

    J. Patino, H. Coco, S. Zadegan, S. Chandra, N. Karagas, N. Rocha, K. Anderson, A. Teixeira, E. Furr Stimming (Houston, USA)

    Objective: To investigate olfactory dysfunction (OD) in individuals with Huntington disease (HD) and its relation to disease severity. Background: HD is a hereditary neurodegenerative disease…
  • 2022 International Congress

    Action verb use in PD: A challenge to the embodied cognition hypothesis?

    E. Nascimento Andrade, C. Manxhari, K. Smith (Worcester, USA)

    Objective: To characterize action verb production in Parkinson's disease (PD) during a picture description task, and evaluate associations with motor and cognitive function. Background: The…
  • 2022 International Congress

    The Efficacy of a Remote Cognitive Remediation Therapy (CRT) Program on Parkinson’s Disease

    N. Piniella, N. Burt, S. Yasin, N. Volino, M. Baker, M. Jung, A. Leder, A. Sousa, L. Hoffman (Glen Head, USA)

    Objective: To determine the feasibility and impact of remote cognitive remediation therapy (CRT) on cognitive function and quality of life (QOL) in patients with Parkinson’s…
  • 2022 International Congress

    Impaired reinforcement learning in patients with cerebellar ataxia

    J. Nicholas, CJ. Amlang, CY. Lin, N. Desai, L. Montaser-Kouhsari, SH. Kuo, D. Shohamy (New York, USA)

    Objective: To further characterize cerebellar learning processes as well as learning impairment pattern in patients with cerebellar dysfunction. Background: Supervised learning (i.e., learning from error)…
  • 2022 International Congress

    Impact of DBS on cognitive functions in Parkinson’s disease in 1 year follow-up

    A. Martinkovičová, Z. Košutzká, M. Pápayová, I. Straka, M. Kľoc, P. Valkovič (Bratislava, Slovakia)

    Objective: The aim of our study was to compare performance in neuropsychology tests in patients with Parkinson’s disease (PD) with implanted electrodes of Deep Brain…
  • 2022 International Congress

    Measuring functional cognition with the Short Weekly Calendar Planning Activity in patients with Parkinson’s disease and non-manifesting LRRK2 and GBA carriers

    T. Schejter Margalit, N. Ben Binyamin, A. Thaler, I. Maidan, J. Cederbaum, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, N. Giladi, A. Mirelman, R. Kizony (Tel Aviv, Israel)

    Objective: The aims of this study were to explore the feasibility of the short Weekly Calendar Planning Activity (WCPA-10) to investigate functional cognition in patients…
  • 2022 International Congress

    Genetic contribution to domain specific cognitive decline

    V. Livneh, N. Omer, N. Giladi, T. Gurevich, A. Bar-Shira, M. Gana-Weisz, O. Goldstein, J. Shirvan, J. Cedarbaum, A. Orr-Urtreger, R. Alcalay, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: To assess differences in cognitive domains  between patients with Parkinson’s disease with the LRRK2 and GBA risk mutations Background: Most patients with PD show…
  • « Previous Page
  • 1
  • …
  • 39
  • 40
  • 41
  • 42
  • 43
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley